ProTime self-management yielding improvement of fluency and quality of life

Summary

Patient self-management (PSM), as the standard of care for vitamin K-antagonist therapy management in Germany requires a detailed, point-of-care (POC) device-specific training program to ensure quality patient care. In a multi-center trial using the ProTime System (Training program plus POC device), 105 patients were enrolled to evaluate efficacy of training, knowledge retention, patient satisfaction and quality of life (QoL). Patients returned to the centers 1, 3 and 6 months after training to complete questionnaires and demonstrate INR test proficiency. Training assessment employed self-evaluation and comparison of POC results between PSM and professional operators. Patient satisfaction and QoL were assessed using a modification of the questionnaire described by Sawicki and the SF12v2 QoL Survey, respectively. Patients demonstrated statistically significant improvements in knowledge post training (p<0.001) and retained the acquired information (p=NS vs. post-training; N=45) after 6 months. Trained patients yielded equivalent INR results to professional operators (r=0.92) with little or no bias across all clinic visits. Compliance with weekly testing improved from 1 to 3 months (p = 0.03), remaining at the required weekly frequency through 6 months. Average patient satisfaction improved significantly during the first month and remained constant thereafter. There was a statistically significant improvement in the Physical Component Summary of SF12 between baseline and 3/6 month assessments in all centers. In conclusion, PSM requires a comprehensive system including appropriate disease and POC device training. Such a system fosters compliance, improved knowledge about underlying disease, patient satisfaction and QoL.

Footnote:

Portions of this trial were presented on November 15, 2005 at the American Heart Association Scientific Sessions 2005 in Dallas, TX, USA.

Keywords

Oral anticoagulation - INR - self-management - quality of life

• References

• 1 Fuster V, Ryden LE, Asinger RW. et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation); North American Society of Pacing and Electrophysiology. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation 2001; 104: 2118-2150.
• 2 Kearon C, Ginsberg JS, Kovacs MJ. et al.; Extended Low-Intensity Anticoagulation for Thrombo-Embolism Investigators. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 2003; 349: 631-639.
• 3 Salem DN, Stein PD, Al-Ahmad A. et al. Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (Suppl. 03) 457S-482S.
• 4 Cannegieter SC, Rosendaal FR, Wintzen AR. et al. Optimal oral anticoagulant therapy in patients with mechanical haeart valves. N Engl J Med 1995; 333: 11-17.
• 5 Ansell J, Hirsh J, Poller L. et al. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (Suppl. 03) 204S-233S.
• 6 Samsa GP, Matchar DB. Relationship between test frequency and outcomes of anticoagulation: A literature review and commentary with implications for the design of randomized trails of patient self-management. J Thromb Thrombolysis 2000; 9: 283-292.
• 7 Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation: A randomized controlled trial. J Am Med Assoc 1999; 281: 145-150.
• 8 Völler H, Dovifat C, Glatz J. et al. Self management of oral anticoagulation with the IN Ratio system: impact of a structured teaching program on patient’s knowledge of medical background and procedures. Eur J Cardiovasc Prev Rehabil 2004; 11: 442-447.
• 9 Völler H, Dovifat C, Wegscheider K. Experience with INR-self-management: Patient selection and complication rates. Z Kardiol 2005; 94: 801-807.
• 10 Oral Anticoagulation Monitoring Study Group.. Point-of-care prothrombin time measurement for professional and patient self-testing use. A multicenter clinical experience. Oral Anticoagulation Monitoring Study Group. Am J Clin Pathol 2001; 115: 288-296.
• 11 Bernardo A, Völler H. Guidelines for patient self-management of oral anticoagulation. Dtsch Med Wschr 2001; 126: 346-351.
• 12 Rosendaal FR, Cannegieter SC, van der Meer FJM. et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-239.
• 13 Christensen TD, Andersen NT, Atterman J. et al. Mechanical heart valve patients can manage oral anticoagulant therapy themselves. Eur J Cardio Thorac Surg 2003; 23: 292-298.
• 14 Cromheecke ME, Levy M, Colly LP. et. al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet 2000; 356: 97-102.
• 15 Koertke H, Korfer R. International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?. Ann Thorac Surg 2001; 71: 44-48.
• 16 Sunderji R, Gin K, Shalansky K. et al. A randomized trial of patients self-managed versus physicianmanaged oral anticoagulation. Can J Cardiol 2004; 20: 1117-1123.
• 17 Siebenhofer A, Berghold A, Sawicki PT. Systematic review of studies of self-management of oral anticoagulation. Thromb Haemost 2004; 91: 225-232.
• 18 Siebenhofer A, Rakovac I, Kleespies C. et al. Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial, Thromb Haemost 2007; 97: 408-416.
• 19 Perry SL, Samsa GP, Ortel TL. Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies. Thromb Haemost 2005; 94: 1196-1202.
• 20 Braun S, Watzke H, Hasenkam JM. et al. Performance evaluation of the new CoaguChek XS system compared with the established CoaguChek system by patients experienced in INR-self management. Thromb Haemost 2007; 97: 310-314.
• 21 Mörsdorf S, Erdlenbruch W, Taborski U. et al. Training of patients for self-management of oral anticoagulant therapy: Standards, patients suitability and clinical aspects. Semin Thromb Hemost 1999; 25: 109-115.
• 22 Kulinna W, Ney D, Wenzel T. et al. The effect of self-monitoring the INR on quality of anticoagulation and quality of life. Semin Thromb Hemost 1999; 25: 123-126.
• 23 Heneghan C, Alonso-Coello P, Garcia-Alamino JM. et al. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006; 367: 404-411.
• 24 Menendez-Jandula B, Souto JC, Oliver A. et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Ann Intern Med 2005; 142: 1-10.